Evidence map›Paper›PMID 36699966›Full record

ArticleIDCases2023

Atypical hemolytic uremic syndrome in a patient with HIV treated with eculizumab: A case report.

Danilo E Trujillo González, Dagoberto Duarte Misol, Nicolás Ariza Ordoñez, Fabian Andres Salgado Zamora, Henry A Millan Prada, Eduardo Zuñiga R, Alejandra Molano Triviño

Open access · goldAbstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in IDCases, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Danilo E Trujillo GonzálezUniversidad del Rosario, Bogotá, Colombia.
Dagoberto Duarte MisolUniversidad del Norte, Barranquilla, Colombia.
Nicolás Ariza OrdoñezUniversidad del Rosario, Bogotá, Colombia.
Fabian Andres Salgado ZamoraUniversidad del Rosario, Bogotá, Colombia.
Henry A Millan PradaLa Cardio, Bogotá, Colombia.
Eduardo Zuñiga RLa Cardio, Bogotá, Colombia.
Alejandra Molano TriviñoLa Cardio, Bogotá, Colombia.
Universidad del Rosario · COInstitute of Cardiology · COUniversidad del Norte · COUniversity of La Salle · CO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombotic microangiopathy defines a group of pathologies characterized by microvascular dysfunction with the concurrence of microangiopathic hemolytic anemia, thrombocytopenia, and organ damage. It represents the most frequent microvascular manifestation of human immunodeficiency virus (HIV) infection. We report the case of a man in the seventh decade of life with a recent diagnosis of infection by HIV, who develops hemolytic uremic syndrome, requiring continuous renal replacement therapy and plasma replacement therapy, without response, ADAMTS13 with preserved activity, ruling out other etiologies (infectious, metabolic, and genetic) with successful response to eculizumab.

Indexed as

Acute kidney injuryAtypical hemolytic uremic syndromeEculizumabHuman immunodeficiency virusPlasma therapeutic exchangeThrombotic microangiopathy

Identifiers

PMID36699966
PMCPMC9867953
OpenAlexW4316041907

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.